ANGO

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Jul 14, 12:14 PMAngioDynamics delivers strong Med Tech-led Q4 growth while FY27 outlook signals slower topline expansion above views

Peers: ICUI MMSI TFX BAX BDX RMD BSX EW MASI MDT

| Held by: VTI IWM VXF IWN SCHA IHI VTWO DFMC DFAS IWC

Scroll to Statements

Index	RUT
Market Cap	594.72M
Enterprise Value	552.25M
Income	-36.74M
Sales	320.17M
Book/sh	4.16
Cash/sh	1.30
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	675
IPO	May 27, 2004

P/E	-
Forward P/E	-
PEG	-
P/S	1.86
P/B	3.46
P/C	11.04
P/FCF	1166.13
EV/EBITDA	876.59
EV/Sales	1.72
Quick Ratio	1.49
Current Ratio	2.19
Debt/Eq	0.07
LT Debt/Eq	0.06
Option/Short	Yes / Yes

EPS (ttm)	-0.89
EPS next Y	-0.04
EPS next Q	-0.12
EPS this Y	-76.67%
EPS next Y	83.02%
EPS next 5Y	-
EPS past 3/5Y	12.67% -1.46%
Sales past 3/5Y	-1.86% 1.93%
EPS Y/Y TTM	25.37%
Sales Y/Y TTM	9.46%
EPS Q/Q	-85.30%
Sales Q/Q	8.05%
Earnings	Jul 14 BMO
EPS/Sales Surpr.	21.96% 7.93%

Insider Own	11.54%
Insider Trans	0.00%
Inst Own	97.94%
Inst Trans	-1.84%
ROA	-13.43%
ROE	-20.77%
ROIC	-20.07%
Gross Margin	51.29%
Oper. Margin	-6.97%
Profit Margin	-11.48%
SMA20	11.61%
SMA50	19.42%
SMA200	24.07%
Trades

Shs Outstand	41.32M
Shs Float	36.55M
Short Float	3.71%
Short Ratio	3.67
Short Interest	1.36M
52W High	13.99 2.88%
52W Low	8.36 72.17%
Volatility	4.20% 3.84%
ATR (14)	0.59
RSI (14)	73.34
Beta	0.34
Rel Volume	4.54
Avg Volume	369.67K
Volume	794,679

Perf Week	12.36%
Perf Month	18.95%
Perf Quarter	37.47%
Perf Half Y	41.39%
Perf YTD	12.10%
Perf Year	66.40%
Perf 3Y	49.46%
Perf 5Y	-44.77%
Perf 10Y	-11.15%
Recom	1.00
Target Price	20.33
Prev Close	13.00
Price	14.39
Change	10.72%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-16-25	Initiated	Lake Street	Buy	$24
Apr-05-24	Upgrade	Oppenheimer	Perform → Outperform	$12
Sep-25-23	Initiated	H.C. Wainwright	Buy	$19
Apr-17-23	Downgrade	Raymond James	Strong Buy → Outperform	$14 → $13
Oct-15-21	Upgrade	Canaccord Genuity	Hold → Buy	$28 → $37
Aug-20-21	Initiated	Oppenheimer	Perform
Nov-25-20	Upgrade	Raymond James	Mkt Perform → Strong Buy	$18
Apr-08-20	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Apr-01-19	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Apr-03-18	Upgrade	Raymond James	Mkt Perform → Outperform
Jan-05-18	Downgrade	Craig Hallum	Buy → Hold
Apr-07-17	Reiterated	Cantor Fitzgerald	Overweight	$20 → $21
Mar-30-17	Downgrade	KeyBanc Capital Mkts	Overweight → Sector Weight
Feb-08-17	Initiated	Barclays	Equal Weight	$17
Nov-04-16	Initiated	Cantor Fitzgerald	Buy
Apr-08-16	Resumed	Piper Jaffray	Neutral
Jan-08-16	Reiterated	Canaccord Genuity	Buy	$17.50 → $14.50
Nov-10-15	Downgrade	Raymond James	Outperform → Mkt Perform
Jul-24-15	Initiated	KeyBanc Capital Mkts	Overweight
Jun-19-14	Upgrade	Canaccord Genuity	Hold → Buy	$16.25 → $20

Show Previous Ratings

Jul-14-26 03:00PM	AngioDynamics Inc (ANGO) Q4 2026 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges (GuruFocus.com)
06:49AM	AngioDynamics Tops Revenue Forecasts and Raises Sales Outlook for Fiscal 2027 (ANGO) (InvestorsHub)
06:18AM	AngioDynamics: Fiscal Q4 Earnings Snapshot (Associated Press)
06:00AM	AngioDynamics Reports Record Fiscal Year 2026 Fourth Quarter and Full Year Financial Results; Continued Execution Drives Med Tech Growth and Full-Year Profitability (Business Wire)
Jun-30-26 08:00AM	AngioDynamics to Report Fiscal 2026 Fourth Quarter and Full-Year Financial Results on July 14, 2026 (Business Wire)
08:30AM	Loading…
Jun-17-26 08:30AM	AngioDynamics Receives FDA IDE Approval for RELIEF Feasibility Study Evaluating NanoKnife IRE Platform as Minimally Invasive Treatment for Benign Prostatic Hyperplasia (BPH) (Business Wire)
May-28-26 01:25PM	AngioDynamics Expands Patient Access to NanoKnife IRE for Prostate and Liver Cancer as Medicare Coverage Framework Takes Effect (Business Wire)
May-27-26 08:30AM	AngioDynamics to Present at the Goldman Sachs 47th Annual Global Healthcare Conference (Business Wire)
May-13-26 09:00AM	AngioDynamics Announces Two-Year PRESERVE Trial Data Demonstrating Durable NanoKnife IRE System Outcomes in Intermediate-Risk Prostate Cancer (Business Wire)
Apr-10-26 08:11PM	AngioDynamics (ANGO) Loses 5.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Quartz)
Apr-02-26 03:00PM	AngioDynamics Inc (ANGO) Q3 2026 Earnings Call Highlights: Strong Revenue Growth Amid Financial ... (GuruFocus.com) -13.65%
12:41PM	AngioDynamics, Inc. Q3 2026 Earnings Call Summary (Moby)
06:11AM	AngioDynamics: Fiscal Q3 Earnings Snapshot (Associated Press)
06:00AM	AngioDynamics Reports Fiscal Year 2026 Third Quarter Financial Results; Sustained Double-Digit Med Tech Growth Drives Continued Profitability (Business Wire)
Mar-31-26 08:00AM	AngioDynamics to Present at the 25th Annual Needham Virtual Healthcare Conference (Business Wire)
08:00AM	Loading…
Mar-19-26 08:00AM	AngioDynamics to Report Fiscal 2026 Third Quarter Results on April 2, 2026 (Business Wire)
Mar-05-26 01:00PM	Veeva Systems' Stock Up After Q4 Earnings & Revenues Beat Estimates (Zacks)
09:31AM	RGTI Stock Down Despite Q4 Earnings Top Estimates, Revenues Decline Y/Y (Zacks)
Mar-02-26 08:25AM	Beat the Market the Zacks Way: Contineum Therapeutics, Suzano, PepsiCo in Focus (Zacks)
Feb-27-26 12:43PM	Clover Health Q4 Earnings Meet Estimates, Sales Beat, Membership Rises (Zacks)
09:40AM	XRAY Stock Gains Despite Q4 Earnings Miss on Restructuring Initiative (Zacks)
Feb-25-26 11:50AM	TMDX Stock Rises as Q4 Earnings & Revenues Beat Estimates (Zacks)
Feb-23-26 04:30PM	AngioDynamics to Present at the Leerink Partners Global Healthcare Conference (Business Wire)
12:42PM	ANGO Expands NanoKnife in Europe for Multi-Organ Tumor Ablation (Zacks)
Feb-19-26 08:30AM	AngioDynamics Expands Indications for the NanoKnife System Across Europe, Strengthening Multi-Organ Tumor Ablation Platform (Business Wire)
Feb-16-26 08:54AM	Here's How Veracyte Stock Is Placed Ahead of Q4 Earnings (Zacks)
Feb-13-26 01:11PM	Waters Q4 Earnings Surpass Estimates, Revenues Increase Y/Y (Zacks)
12:35PM	DexCom Stock Falls Despite Q4 Earnings Beat, G7 Rollout Drives Growth (Zacks)
Feb-06-26 09:55AM	Does AngioDynamics (ANGO) Have the Potential to Rally 92.15% as Wall Street Analysts Expect? (Zacks)
Feb-05-26 11:30AM	AngioDynamics (ANGO) Down 3.9% Since Last Earnings Report: Can It Rebound? (Zacks)
08:00AM	Loading…
08:00AM	AngioDynamics and The PERT Consortium Launch Investigator-Led Research Fund to Advance Pulmonary Embolism Care (Business Wire)
Feb-04-26 12:51PM	Here's Why You Should Add Masimo Stock to Your Portfolio Now (Zacks)
Feb-03-26 08:00AM	AngioDynamics to Convene Cardiovascular Leaders at Scientific Forum as Pipeline Continues to Advance (Business Wire)
Jan-30-26 09:55AM	Here's Why AngioDynamics (ANGO) Is a Great 'Buy the Bottom' Stock Now (Zacks)
Jan-29-26 12:47PM	Reasons to Add AngioDynamics Stock to Your Portfolio for Now (Zacks)
Jan-14-26 07:04PM	AngioDynamics J.P. Morgan Conference: MedTech Growth Push, Cash-Flow Path, CEO Retirement Plan (MarketBeat) +7.62%
10:13AM	The Zacks Analyst Blog Highlights AngioDynamics, Boston Scientific and Medtronic (Zacks)
Jan-13-26 01:40PM	3 MedTech Stocks Benefiting From Favorable Product Mix Shifts (Zacks)
Jan-12-26 09:35AM	Down 25.0% in 4 Weeks, Here's Why You Should You Buy the Dip in AngioDynamics (ANGO) (Zacks)
Jan-07-26 12:11PM	ANGO Stock Dips Despite Q2 Earnings Beat, Gross Margin Improves (Zacks)
Jan-06-26 02:00PM	AngioDynamics Inc (ANGO) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com) -13.53%
11:24AM	Why AngioDynamics Stock Is Sinking Today (Motley Fool)
09:27AM	AngioDynamics: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
09:03AM	AngioDynamics Q2 Earnings Call Highlights (MarketBeat)
06:00AM	AngioDynamics Reports Fiscal Year 2026 Second Quarter Financial Results; Continued Double Digit Med Tech Growth Drives Increased Profitability (Business Wire)
Dec-24-25 12:29PM	Reasons to Hold AngioDynamics Stock in Your Portfolio for Now (Zacks)
Dec-23-25 08:00AM	AngioDynamics to Report Fiscal 2026 Second Quarter Results on January 6, 2026 (Business Wire)
Dec-22-25 08:00AM	AngioDynamics to Present at the 44th Annual J.P. Morgan Healthcare Conference (Business Wire)
Nov-21-25 10:50AM	Reasons to Hold AngioDynamics Stock in Your Portfolio for Now (Zacks)
Oct-27-25 04:30PM	AngioDynamics to Participate in the UBS Global Healthcare Conference (Business Wire)
Oct-26-25 06:16AM	H.C. Wainwright Reaffirms Buy Rating on AngioDynamics (ANGO) After Strong Q1 Performance (Insider Monkey)
Oct-13-25 08:30AM	AngioDynamics NanoKnife System Named to TIMEs 2025 Best Inventions List (Business Wire)
Oct-03-25 12:47PM	AngioDynamics Eyes Growth Despite Tariffs (Benzinga)
08:21AM	ANGO Stock Gains Following Q1 Earnings Beat, Gross Margin Improves (Zacks)
Oct-02-25 03:01PM	AngioDynamics Inc (ANGO) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Raised ... (GuruFocus.com) +6.05%
12:28PM	Why Did AngioDynamics Stock Pop Today? (Motley Fool)
07:10AM	AngioDynamics (ANGO) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
06:08AM	AngioDynamics: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
06:00AM	AngioDynamics Reports Fiscal Year 2026 First Quarter Financial Results; Med Tech Growth of 26.1% Drives Continued Momentum (Business Wire)
Oct-01-25 09:15AM	Earnings To Watch: AngioDynamics Inc (ANGO) Reports Q1 2026 Result (GuruFocus.com)
Sep-22-25 12:27PM	Reasons to Hold AngioDynamics Stock in Your Portfolio for Now (Zacks)
Sep-18-25 08:00AM	AngioDynamics to Report Fiscal 2026 First Quarter Results on October 2, 2025 (Business Wire)
Sep-09-25 06:45PM	Nutriband Inc. (NTRB) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
Aug-28-25 11:30AM	Why Is Penumbra (PEN) Up 5% Since Last Earnings Report? (Zacks)
Aug-21-25 01:30PM	Reasons to Hold AngioDynamics Stock in Your Portfolio for Now (Zacks)
Aug-14-25 04:04AM	Europe Neonatal Intensive Care Market Growth and Company Analysis Report 2025-2033 Featuring Masimo, 3M, Medtronic, Koninklijke Philips, Siemens, Terumo, AngioDynamics, Dragerwerk (GlobeNewswire)
Aug-06-25 04:30PM	AngioDynamics to Present at the Canaccord Genuity 45th Annual Growth Conference (Business Wire)
Jul-28-25 08:30AM	AngioDynamics Enrolls First Patient in AMBITION BTK Trial Advancing Treatment for Critical Limb Ischemia (Business Wire)
Jul-25-25 11:13AM	Venous Thromboembolism Treatment Devices Market Insights, Competitive Landscape, and Forecast Report 2032 Featuring Abbott, Boston Scientific, AngioDynamics, Argon Medical Devices, and Medtronic (GlobeNewswire)
Jul-23-25 08:30AM	AngioDynamics Announces Publication of PRESERVE Study of NanoKnife System for Prostate Tissue Ablation in European Urology (Business Wire)
Jul-18-25 07:02AM	Tumor Ablation Market Research Report 2025-2032 \| Radiofrequency Ablation Leads, Offering Efficiency and Specificity Across Key Organ Treatments (GlobeNewswire)
Jul-16-25 12:35PM	ANGO Stock Down Despite Q4 Earnings Beat, Gross Margin Declines (Zacks)
03:03AM	AngioDynamics Inc (ANGO) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Tariff ... (GuruFocus.com)
Jul-15-25 04:42PM	Why AngioDynamics Stock Popped, Then Dropped Today (Motley Fool) -10.18%
07:40AM	AngioDynamics (ANGO) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
06:44AM	AngioDynamics: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
06:30AM	AngioDynamics Reports Strong Fiscal Year 2025 Fourth Quarter and Full Year Financial Results; Continued Execution Driving Accelerated, Profitable Growth (Business Wire)
Jul-14-25 09:18AM	What To Expect From AngioDynamics Inc (ANGO) Q4 2025 Earnings (GuruFocus.com)
Jul-07-25 08:00AM	AngioDynamics to Report Fiscal 2025 Fourth Quarter and Full-Year Financial Results on Tuesday, July 15, 2025 (Business Wire)
Jun-26-25 10:55AM	SNN Expands Orthopedic Portfolio With Advanced Tibia Nailing System (Zacks)
08:23AM	Reasons to Retain TransMedics Stock in Your Portfolio for Now (Zacks)
Jun-24-25 10:43AM	Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now (Zacks)
Jun-23-25 08:00AM	AngioDynamics Announces First Patient Enrolled in RECOVER-AV Clinical Trial Evaluating AlphaVac F1885 System for Treatment of Acute Pulmonary Embolism (Business Wire)
Jun-20-25 11:40AM	Smith+Nephew Stock May Gain From Strategic Deal With Standard Health (Zacks)
11:36AM	Here's Why You Should Retain Ecolab Stock in Your Portfolio Now (Zacks)
Jun-18-25 09:55AM	GE HealthCare Stock Slips Despite the Launch of bkActiv S Series (Zacks)
09:52AM	Here's Why You Should Hold Accuray Stock in Your Portfolio for Now (Zacks)
Jun-17-25 11:39AM	VEEV Stock May Gain on the Launch of China Campaign Manager for Pharma (Zacks) -6.01%
Jun-16-25 11:14AM	INBS Stock May Rise on SMARTOX Partnership Expanding Forensic Reach (Zacks)
Jun-13-25 12:37PM	Here's Why You Should Retain OPKO Health Stock in Your Portfolio (Zacks)
Jun-11-25 10:28AM	Reasons to Add DENTSPLY SIRONA Stock to Your Portfolio Now (Zacks)
Jun-09-25 11:55AM	ZimVie Stock Gains Following the Launch of RealGUIDE Software Suite (Zacks)
11:35AM	Zacks Industry Outlook Penumbra, Integer and AngioDynamics (Zacks)
Jun-06-25 12:26PM	NVCR Stock Dips Despite Positive OS Data From Phase 3 PANOVA-3 Trial (Zacks)
09:41AM	3 Medical Instruments Stocks Winning Big With GenAI Amid Global Gloom (Zacks)
Jun-05-25 12:07PM	Here's Why You Should Add PacBio Stock to Your Portfolio Now (Zacks)
Jun-04-25 12:31PM	Reasons to Add Fresenius Medical Stock to Your Portfolio Now (Zacks)
12:26PM	HealthEquity Stock Gains as Q1 Earnings Beat Estimates, Revenues Up Y/Y (Zacks)
12:00PM	What Makes AngioDynamics (ANGO) a Strong Momentum Stock: Buy Now? (Zacks)
Jun-03-25 12:10PM	Hyperfine Stock Rises After FDA Clears Next-Gen Swoop MRI System (Zacks) +12.89%

AngioDynamics, Inc. is a medical device company, which engages in the development, manufacturing, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The firm offers ablation systems, fluid management systems, vascular access, angiographic, drainage, thrombolytic, and venous products. It operates through the Med Tech and Med Device segments. The Med Tech segment consists of technology portfolio including Auryon, the thrombus management platform and NanoKnife. The Med Device segment focuses on core, venous, ports, and other oncology products. The company was founded by Howard S. Stern and Eamonn P. Hobbs on February 9, 1988 and is headquartered in Latham, NY.

CEOMr. James C. Clemmer

Executive VP & CFOMr. Stephen A. Trowbridge

Senior VPMr. Lawrence T. Weiss

Senior Vice President of Regulatory AffairsMr. Warren G. Nighan

Senior VP and GM of Cardiovascular & InternationalMs. Laura Piccinini

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Weiss Lawrence T	SVP, Chief Legal Officer	Oct 21 '25	Buy	11.81	10,000	118,100	93,597	Oct 22 07:00 AM
Trowbridge Stephen A	EVP and CFO	Oct 13 '25	Buy	11.16	890	9,932	256,629	Oct 14 06:11 AM
Clemmer James C	President and CEO	Oct 09 '25	Buy	11.15	10,000	111,500	882,529	Oct 09 09:09 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Angiodynamic Inc

Upgrade your Finviz experience